Proceedings of the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: evidence-based guidelines

Chest

Abstract

Since the Sixth American College of Chest Physicians Consensus Conference on Antithrombotic Therapy, the results of clinical trials have provided important new information on the management of thromboembolic disorders, and the science of developing recommendations has advanced. In the accompanying supplement, we provide the new and previously existing recommendations and review several important changes that we have made in our guideline development process. We made a conscious effort to increase the participation of female authors and of contributors from outside North America, with the latter reflecting the widespread use and dissemination of these guidelines internationally. The change in the title from a conference emphasizing consensus to "ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines" reflects the evidence-based approach to making recommendations. The recommendations follow the grading system described in the 2001 recommendations. If the guideline developers are very certain that benefits do, or do not, outweigh risks, burdens, and costs, they will make a strong recommendation (in our formulation, Grade 1). If they are less certain of the magnitude of the benefits and the risks, bur...Continue Reading

Citations

Jul 25, 2007·Archives of Internal Medicine·Frederick A SpencerRobert J Goldberg
Feb 27, 2008·Archives of Internal Medicine·Frederick A SpencerRobert J Goldberg
Jul 16, 2008·Archives of Neurology·Hen HalleviJames C Grotta
Jun 13, 2006·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Thomas Lecompte, Jean-François Hardy
Jan 12, 2007·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·A Tiede
Nov 26, 2010·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·H H HoC-W Siu
Oct 6, 2010·Analytical and Bioanalytical Chemistry·Mette SchroederKristian B Johansen
May 1, 2007·International Orthopaedics·Takeshi FujiTakahiro Ochi
Oct 18, 2008·International Orthopaedics·Stavros G MemtsoudisAlejandro González Della Valle
May 27, 2011·International Orthopaedics·Enis GuryelMartin Bircher
Jul 4, 2009·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Antonio KruegerSteffen Ruchholtz
May 3, 2007·Journal of Genetic Counseling·Elizabeth Varga
Feb 14, 2006·Journal of Thrombosis and Thrombolysis·Kenneth A Bauer
May 19, 2007·Journal of Thrombosis and Thrombolysis·Richard C Becker
Oct 2, 2007·Journal of Thrombosis and Thrombolysis·Wendy A Leong
Feb 23, 2010·Journal of Thrombosis and Thrombolysis·Erin M GalbraithJames B Froehlich
Feb 18, 2011·Journal of Thrombosis and Thrombolysis·Allison BurnettDavid Garcia
Mar 14, 2007·Journal of General Internal Medicine·John T PhilbrickDaniel M Becker
Apr 1, 2008·Journal of General Internal Medicine·Mark L WessMark H Eckman
Mar 4, 2009·Journal of General Internal Medicine·Mark H EckmanJonathan Rosand
Apr 9, 2009·Journal of General Internal Medicine·Amir K JafferBarbara Slawski
Apr 24, 2009·Journal of General Internal Medicine·Christopher A K Y ChongMurray D Krahn
Apr 15, 2010·Journal of General Internal Medicine·Diane Sliwka, Margaret C Fang
Sep 29, 2011·Journal of General Internal Medicine·Raman KhannaAndrew Auerbach
Jun 7, 2007·Internal and Emergency Medicine·M MariettaG Torelli
Sep 23, 2008·Internal and Emergency Medicine·Giuseppe Stefano NettiLoreto Gesualdo
Jul 7, 2009·International Journal of Behavioral Medicine·Dean G CruessStephen E Kimmel
Jul 13, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·George A LopezOwen Samuels
Mar 12, 2005·Archives of Physical Medicine and Rehabilitation·Ali A BitarLeonard B Kamen
May 26, 2009·The Annals of Thoracic Surgery·Bachar El OumeiriGébrine El Khoury
Aug 21, 2013·Best Practice & Research. Clinical Haematology·Alexander Ander T Cohen, Tom Rider
Aug 21, 2013·Best Practice & Research. Clinical Haematology·N Bennaghmouch, J M Ten Berg
May 19, 2005·Disease-a-month : DM·Joseph A Caprini
May 19, 2005·Disease-a-month : DM·John E Rectenwald, Thomas W Wakefield
May 19, 2005·Disease-a-month : DM·Anthony J Comerota
May 19, 2005·Disease-a-month : DM·Theodore E Warkentin
May 19, 2005·Disease-a-month : DM·Thomas M Hyers
Dec 26, 2006·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Joel Dunning

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved